Show Summary Details
Page of

General aspects 

General aspects
General aspects

Andrea Rubboli

, David P. Faxon

, Axel Schlitt

, and Gregory Y. H. Lip

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 October 2020

About 5-8% of patients referred for percutaneous coronary intervention (PCI) have an indication for oral anticoagulation.Atrial fibrillation is indicated for oral anticoagulation in nearly 70% of these patients, and coronary artery disease co-exists in 20-30% of cases.One-and-half to two million people aretreated with oral anticoagulants in Europe, and North America are candidates for percutaneous coronary intervention.Proper management of percutaneous coronary intervention procedures, as well as post-discharge antithrombotic therapy,are warranted to balance the risk of bleeding against those of thromboembolism, stent thrombosis, and adverse cardiac events.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.